About
Psychedelic Compounds
Areas of Focus
Categories
Small Molecule PharmaceuticalPsychedelic
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
6
As Collaborator
1
Total Enrollment
459
By Phase
PHASE2: 3PHASE1/PHASE2: 1PHASE1: 3
By Status
COMPLETED: 4ACTIVE_NOT_RECRUITING: 2TERMINATED: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05870540Lead Sponsor
BPL-003 Efficacy and Safety in Treatment Resistant Depression
PHASE2Completed
196 participants
Started: Sep 14, 2023 · Completed: Jul 3, 2025
NCT05674929Lead Sponsor
An Open-Label, Single Dose Study in Patients With Alcohol Use Disorder
PHASE2Completed
13 participants
Started: May 30, 2023 · Completed: Oct 2, 2024
NCT05660642Lead Sponsor
An Open-Label Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression
PHASE2Active, not recruiting
64 participants
Started: Feb 10, 2023 · Completed: Jul 31, 2025
NCT05434156Collaborator
ELE-101 Safety & Tolerability Study in Healthy Participants and Patients With Depression
PHASE1/PHASE2Active, not recruiting
84 participants
Started: Oct 27, 2022 · Completed: Mar 31, 2026
NCT05347849Lead Sponsor
Single Ascending Dose Study With BPL-003 in Healthy Subjects
PHASE1Completed
62 participants
Started: Feb 14, 2022 · Completed: Jan 19, 2024
Funding History (1)
D
Jun 8, 2021
Locations (1)
Headquarters
Beckley, UK
Map
Loading map...